MissionIR's  Instablog

Send Message
We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices. It is our unwavering commitment to connect the investment community with companies that have great potential and a strong dedication to... More
My company:
My blog:
MissionIR Blog
  • SciClone Pharmaceuticals, Inc. (SCLN) Announces Wilson W. Cheung As Chief Financial Officer 0 comments
    Jul 15, 2013 6:21 PM | about stocks: SCLN

    SciClone Pharmaceuticals announced earlier today the recruitment of Wilson W. Cheung to the position of Chief Financial Officer and Senior Vice President of Finance. A seasoned executive with senior financial and international accounting experience, Cheung has a wealth of knowledge in financial management, SEC, and SOX 404 financial reporting for publicly traded international companies. He also retains strong experience in investor relations, corporate governance and compliance, operations management, and corporate development. Reporting to Friedhelm Blobel, Ph.D., Chief Executive Officer, Cheung will be based in the company's headquarters in Foster City, CA.

    "Wilson has extensive experience in managing financial operations and compliance for commercial, publicly traded companies and has a deep understanding of companies operating in China in highly regulated, competitive and fast changing environments," stated Dr. Blobel. "His international, multi-industry experience will be especially valuable as our Company implements strategies to drive our long-term growth, expand the market opportunities for ZADAXIN®, develop the potential of our growing portfolio of differentiated products, and strengthen our standing as a US-based, China-focused specialty pharmaceutical company. I am particularly pleased with the significant strengthening of SciClone's management team in the US and China over the last several quarters, and believe that Wilson will be a great addition to our executive team."

    "I believe that SciClone is an exciting, growth-oriented specialty pharmaceutical company with excellent prospects for delivering impressive financial results and building shareholder value," Cheung commented. "I appreciate the opportunity to work with the highly dedicated finance teams in the US and China to maintain timely and high quality financial reporting, and to help strengthen SciClone's market success and reputation within the investor community."

    Most recently Cheung held the title of Chief Compliance Officer, Asia Pacific of Velti plc, a global mobile marketing and advertising software provider, and prior to that acted as Chief Financial Officer, in which he took the company public on its Nasdaq IPO, raising over $400 million in equity and debt as well as oversaw investor relations and global finance. Cheung also spent time as Chief Financial Officer and Corporate Secretary at AXT, Inc., a California-based, publicly traded manufacturer. Additionally, Cheung has held senior financial positions at telecommunications company InterWAVE Communications International Ltd. (now Alvarion, Ltd), Yahoo!, Deloitte, and KPMG.
    Cheung impressively speaks English, Cantonese, and Mandarin. A California Certified Public Accountant (inactive), Cheung holds a B.A. from the University of California, Los Angeles (UCLA), and a Certified Director of Corporate Governance from UCLA's Executive Program.

    For additional information, please visit www.sciclone.com

    Please see disclaimer on the MissionIR website

    Stocks: SCLN
Back To MissionIR's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.